12-month controlled study in the United States of the safety and efficacy of a permanent 2.5% polyacrylamide hydrogel soft-tissue filler

Dermatologic Surgery

Volumn 36, Issue SUPPL. 3, 2010, Pages 1819-1829

  Narins, Rhoda S ^a,b   Coleman III, William P ^c   Rohrich, Rodney ^d   Monheit, Gary ^e   Glogau, Richard ^f   Brandt, Fredric ^g   Bruce, Suzanne ^h   Colen, Lawrence ⁱ   Dayan, Steven ^j   Jackson, Ian ^k   Maas, Corey ^l   Rivkin, Alexander ^m,n   Sclafani, Anthony ^o   Spivak, Joan C ^p  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Dermatology Surgery and Laser Center of New York   (United States)

^c TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e Total Skin and Beauty Dermatology Center   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Dermatology Research Institute LLC   (United States)

^h Center for Skin Research   (United States)

ⁱ EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^j Dayan Facial Plastic Surgery   (United States)

^k PROVIDENCE HOSPITAL   (United States)

^l Maas Clinic   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ Westside Aesthetics   (United States)

^o NEW YORK EYE AND EAR INFIRMARY   (United States)

^p Spivak Consulting   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLOBETASOL; COSMETIC; HYALURONIC ACID; LINEZOLID; POLYACRYLAMIDE HYDROGEL; UNCLASSIFIED DRUG; VANCOMYCIN;

ADULT; ARTICLE; BREAST CANCER; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INJECTION SITE CONTUSION; INJECTION SITE EDEMA; INJECTION SITE INDURATION; INJECTION SITE INFECTION; INJECTION SITE INFLAMMATION; INJECTION SITE IRRITATION; INJECTION SITE PAIN; INJECTION SITE REACTION; INJECTION SITE SWELLING; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NASOLABIAL FOLD; OSTEOARTHRITIS; PANIC; PELVIS FRACTURE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN DEFECT; SKIN REDNESS; SKIN TINGLING; SQUAMOUS CELL CARCINOMA; THORAX PAIN; UNITED STATES; UTERUS CANCER; WRINKLE; WRINKLE ASSESSMENT SCALE;

EID: 78349255346     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01736.x     Document Type: Article

References (39)

1. Bergeret-Galley C., Comparison of resorbable soft tissue fillers. Aesthet Surg J 2004; 24: 33-46.
2. ™ in esthetic rejuvenation. Sem Cut Med Surg 2006; 25: 127-31.
3. Broder KW, Cohen SR., An overview of permanent and semipermanent fillers. Plast Reconstr Surg 2006; 118 (Suppl): 7S-14S.
4. Tzikas T., A 52-month summary of results using calcium hydroxyapatite for facial soft tissue augmentation. Dermatol Surg 2008; 34: S9-15.
5. Murray CA, Zloty D, Warshawski L., The evolution of soft tissue fillers in clinical practice. Dermatol Clin 2005; 23: 343-63.
6. Cooperman LS, Mackinnon V, Bechler G, Pharriss BB., Injectable collagen: a six-year clinical investigation. Aesth Plast Surg 1985; 9: 145-51.
7. Castrow FF II, Krull EA., Injectable collagen implant-update. J Am Acad Dermatol 1983; 9: 889-93.
8. Monstrey SJ, Pitaru S, Hamdi M, et al,. A two-stage phase 1 trial of Evolence30 collagen for soft-tissue contour correction. Plast Reconstr Surg 2007; 120: 303-11.
9. Narins RS, Brandt FS, Lorenc P, et al,. Twelve-month persistency of a novel ribose-cross-linked collagen dermal filler. Dermatol Surg 2008; 34 S1: 31 9.
10. Nir F, Azachi M, Shoshani D, Goldlust, Long term in vivo evaluation of the safety and efficacy of a new porcine collagen dermal filler cross-linked with ribose. Poster presented at the American Academy of Dermatology 66th Annual Meeting, San Antonio, TX, February 2008.
11. American Society for Aesthetic Plastic Surgery, Cosmetic Surgery National Data Bank: 2008 Statistics. Available from. Accessed April 2009.
12. Lowe NJ, Maxwell CA, Patnaik R., Adverse reactions to dermal fillers: review. Dermatol Surg 2005; 31 (11 Pt 2): 1616-25.
13. Narins RS, Brandt F, Leyden J, et al,. A randomized, double-blind multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003; 29: 588-95.
14. Cohen SR, Berner CF, Busso M, et al,. Five-year safety and efficacy of a novel polymethylmethacrylate aesthetic soft tissue filler for the correction of nasolabial folds. Dermatol Surg 2007; 33 (s2): s222-30.
15. Prescribing Information for Sculptra Aesthetic (injectable poly-L-lactic acid), Dermik Laboratories, Bridgewater, NJ, as of July 2009
16. Summary of Safety and Effectiveness Data for Sculptra Aesthetic, Notice of Approval July 28, 2009 Available at (accessed September 10, 2010).
17. Narins RS, Beer K., Liquid injectable silicone: a review of its history, immunology, technical considerations, complications, and potential. Plast Reconstr Surg 2006; 118 (Suppl): 77S-84S.
18. Christensen L., Normal and pathologic tissue reactions to soft tissue gel fillers. Dermatol Surg 2007; 33: S168-75.
19. Christensen LH, Breiting VB, Aasted A, et al,. Long-term effects of polyacrylamide hydrogel on human breast tissue. Plast Reconstr Surg 2003; 111: 1883-90.
20. Christensen L, Breiting V, Vuust J, Hogdall E., Adverse reactions following injection with a permanent facial filler polyacrylamide hydrogel (Aquamid): causes and treatment. Eur J Plast Surg 2006; 28: 464-71.
21. Christensen L, Breiting V, Janssen M, et al,. Adverse reactions to injectable soft tissue permanent fillers. Aesth Plast Surg 2005; 29: 34-48.
22. Bello G, Jackson IT, Keskin M, et al,. The use of polyacrylamide gel in soft tissue augmentation: an experimental assessment. Plast Reconst Surg 2007; 119: 1326-36.
23. De Cassia Novaes W, Berg A., Experiences with a new nonbiodegradable hydrogel (Aquamid): a pilot study. Aesth Plast Surg 2003; 27: 376-80.
24. Zarini E, Supino R, Pratesi G, et al,. Biocompatibility and tissue interactions of a new filler material for medical use. Plast Reconstr Surg 2004; 114: 934-42.
25. Von Buelow S, Von Heimburg D, Pallua N., Efficacy and safety of polyacrylamide hydrogel for facial soft tissue augmentation. Plast Reconstr Surg 2005; 116: 1137-46.
26. Von Buelow S, Pallua N., Efficacy and safety of polyacrylamide hydrogel for facial soft tissue augmentation in a 2 year follow up: a prospective multicenter study for evaluation of safety and aesthetic results in 101 patients. Plast Reconstr Surg 2006; 118: 85S-91S.
27. Wolters M, Lampe H., Prospective multicenter study for evaluation of safety, efficacy, and esthetic results of cross-linked polyacrylamide hydrogel in 81 patients. Dermatol Surg 2009; 35: S338-43.
28. Lemperle G, Morhenn V, Charrier U., Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesth Plat Surg 2003; 27: 354-66.
29. Lemperle G, Holmes RE, Cohen SR, Lemperle SM., A classification of facial wrinkles. Plast Reconstr Surg 2001; 108: 1735-50.
30. DeLorenzi C, Weinberg M, Solish N, Swift A., A multicenter study of the efficacy and safety of subcutaneous nonanimal stabilized hyaluronic acid in aesthetic facial contouring: interim report. Dermatol Surg 2006; 32: 205-11.
31. Narins RS, Dayan SH, Brandt FS, Baldwin EK., Persistence and improvement of nasolabial fold correction with nonanimal stabilized hyaluronic acid 100,000 gel particles/mL filler on two retreatment schedules: results up to 18 months on two retreatment schedules. Dermatol Surg 2008; 34: S2-8.
32. Wang F, Garzu LA, Kang S, et al,. In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermatol 2007; 143: 155-63.
33. Fagien S., Facial soft-tissue augmentation with injectable autologous and allogenic human tissue collagen matrix (Autologen and Dermatologen). Plast Reconstr Surg 2000; 105: 362-73.
34. Alijotas-Reig J, Garcia-Gimenez V, Miro-Mur F, Vilardell-Tarres M., Delayed immune-mediated adverse effects related to polyacrylamide dermal fillers: clinical findings, management and follow-up. Dermatol Surg 2009; 35: 360-6.
35. Liu HL, Cheung WY., Complications of polyacrylamide hydrogel (PAAG) injection in facial augmentation. J Plast, Reconstr Aesth Surg 2010; 63: e9-12.
36. Abenavoli F, Servili A, Corelli R., Aquamid: where is the reality? (letter). Plast Reconstr Surg 2008; 122: 32e-3e.
37. Yagi Y, Kato K, Murakami D, et al,. Use of Aquamid as a filler for facial rejuvenation in Orientals. Plast Reconstr Surg 2009; 62: 1245-9.
38. Wolter TP, Pallua N., A 5-year assessment of safety and aesthetic results after facial soft-tissue augmentation with polyacrylamide hydrogel (Aquamid): a prospective multicenter study of 251 patients. Plast Reconstr Surg 2010; 125: 1797-1804.
39. Bjarnsholt T, Tolker-Nielsen T, Givskov M, et al,. Detection of bacteria by FISH in culture-negative soft tissue filler lesions. Dermatol Surg 2009; 35: 1620-24.